Erratum: Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients (Annals of Oncology (2001) vol. 12 (8) (1097-1106))

Creators: Venturini M.; Michelotti A.; Papaldo P.; Del Mastro L.; Bergaglio M.; Lionetto R.; Lunardi G.; Sguotti C.; Frevola L.; Donati S.; Rosso R.; Cognetti F.

Others:: Venturini, M.; Michelotti, A.; Papaldo, P.; Del Mastro, L.; Bergaglio, M.; Lionetto, R.; Lunardi, G.; Sguotti, C.; Frevola, L.; Donati, S.; Rosso, R.; Cognetti, F.

Additional details